Executive Vice President, Liver Disease Program
Jonathan Adams, MBA, founded the predecessor company to BioVie in 2007 and has over 30 years of biopharmaceutical industry experience. This includes finance, acquisitions and licensing, technology commercialization, global product launches, marketing and sales force management. At Searle Pharmaceuticals he was a member of the global launch team for Celebrex and performed key roles in product branding, market research, medical education, and other areas. Subsequently, he worked in technology commercialization for next-generation COX-2 inhibitors. After Searle, Mr. Adams worked in account management for healthcare advertising agencies and developed expertise in a wide range of therapeutic areas while helping his clients to launch dozens of new drugs and devices. He served as a marketing leader for Mission Pharmacal’s urology division before dedicating full-time attention to BioVie beginning in 2018. Mr. Adams earned a BS at Cornell University and an MBA at the Tuck School at Dartmouth.